Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Y-27632 Dihydrochloride: Selective ROCK Inhibitor for Cel...

    2025-11-17

    Y-27632 Dihydrochloride: Selective ROCK Inhibitor for Cell-Based Research

    Principle and Setup: The Foundation of Rho/ROCK Signaling Modulation

    Y-27632 dihydrochloride (SKU: A3008) from APExBIO is a cell-permeable, highly selective inhibitor targeting Rho-associated protein kinases, specifically ROCK1 and ROCK2. With an IC50 of approximately 140 nM for ROCK1 and a Ki of 300 nM for ROCK2, Y-27632 dihydrochloride exhibits over 200-fold selectivity relative to kinases such as PKC, cAMP-dependent protein kinase, MLCK, and PAK. This potent selectivity makes it the gold standard for dissecting the intricacies of the Rho/ROCK signaling pathway in applications ranging from cytoskeletal studies and cell cycle analyses to stem cell viability enhancement and tumor invasion suppression.

    ROCK kinases, acting downstream of Rho GTPases, orchestrate cytoskeletal rearrangements, stress fiber formation, and cell contractility. By inhibiting these kinases, Y-27632 disrupts Rho-mediated stress fiber formation, modulates cell cycle progression from G1 to S phase, and impedes cytokinesis—factors crucial in both stem cell biology and oncology. Its robust aqueous solubility (≥52.9 mg/mL) and compatibility with DMSO and ethanol facilitate diverse experimental setups, while its stability profile ensures consistency across in vitro and in vivo workflows.

    Step-by-Step Workflow: Protocol Enhancements with Y-27632 Dihydrochloride

    Stem Cell Derivation and Maintenance

    One of the most impactful applications for this Rho-associated protein kinase inhibitor is in the derivation, expansion, and maintenance of pluripotent stem cells. A recent protocol detailed in Yu et al., Methods Mol Biol., 2023 demonstrates the critical role of ROCK inhibition during the establishment of intermediate pluripotent stem cells (FTW-PSCs). Here’s an optimized approach leveraging Y-27632 dihydrochloride:

    • Preparation of MEF Feeder Cells: Plate and irradiate mouse embryonic fibroblasts (MEFs) as per standard protocols to provide a supportive niche.
    • Cell Dissociation and Plating: Following enzymatic dissociation with TrypLE or Trypsin-EDTA, supplement culture media with 10 μM Y-27632 dihydrochloride for the initial 24-48 hours post-passage. This concentration is widely validated to significantly reduce apoptosis during single-cell dissociation, supporting robust colony formation.
    • Culture Expansion: For both mouse and human FTW-PSCs, maintain cells in FTW medium (FGF, TGF-β, and WNT pathway activators) with intermittent Y-27632 supplementation during passaging or stress conditions. This preserves cell viability and maintains pluripotency markers, as confirmed by flow cytometry and gene expression profiling.

    Tumor Invasion and Metastasis Assays

    In cancer research, Y-27632 dihydrochloride is employed to interrogate mechanisms of tumor cell migration and invasion. In Matrigel invasion chambers or wound healing assays, addition of 10–30 μM Y-27632 disrupts actomyosin contractility, quantifiably reducing cell motility and invasion rates by up to 60% in aggressive cancer cell lines (see Mouse IFN-α resource). This allows for precise delineation of ROCK-dependent invasion pathways and evaluation of therapeutic interventions.

    Cytokinesis and Cell Proliferation Assays

    For cell proliferation assays, Y-27632 dihydrochloride’s inhibition of cytokinesis is leveraged to synchronize cell cycle progression, enabling clearer interpretation of cell cycle transitions. For instance, prostatic smooth muscle cell proliferation is significantly reduced in a concentration-dependent manner, with 50% inhibition observed at sub-micromolar concentrations (IC50 ≈ 0.14 μM for ROCK1).

    Advanced Applications and Comparative Advantages

    Organoid Culture and Extracellular Vesicle Studies

    The utility of Y-27632 dihydrochloride extends to advanced organoid and 3D cell culture systems. Its inclusion during the initial embedding and expansion phases enhances organoid forming efficiency, viability, and morphological fidelity. According to Lamimin-925-933 resource, this cell-permeable ROCK inhibitor for cytoskeletal studies also modulates extracellular vesicle release, opening new avenues in intercellular signaling research. By finely tuning the concentration (typically 5–20 μM), researchers can promote robust 3D structure formation while minimizing off-target effects.

    Comparative Advantage Over Alternative Inhibitors

    Compared to less selective kinase inhibitors, Y-27632 dihydrochloride’s >200-fold selectivity for ROCK1/2 minimizes confounding signaling perturbations. This high specificity is crucial for mechanistic studies in the Rho/ROCK signaling pathway, enabling reproducible results vital for both basic and translational research. As highlighted in Papilostatin-2 review, such selectivity is indispensable for reliable cytoskeletal modulation in organoid and cancer models.

    Synergy with Regenerative and Cancer Research

    Y-27632 dihydrochloride is a cornerstone in workflows requiring stem cell viability enhancement and tumor invasion/metastasis suppression. When combined with pathway-specific growth factors and matrix components, it facilitates high-efficiency reprogramming, chimera formation, and in vitro germ cell specification, as established in the referenced Methods Mol Biol. protocol. Its antitumoral effects are also supported by data showing reduced tumor burden and metastatic spread in mouse models, underscoring its translational relevance.

    Troubleshooting and Optimization Tips

    • Solubility Optimization: Y-27632 dihydrochloride is highly soluble in DMSO (≥111.2 mg/mL), ethanol (≥17.57 mg/mL), and water (≥52.9 mg/mL). If precipitation occurs, gently warm solutions to 37°C or use an ultrasonic bath for rapid dissolution. For cell-based assays, prepare fresh aliquots and avoid repeated freeze-thaw cycles to maintain activity.
    • Concentration Titration: Start with 10 μM for most stem cell and cancer cell workflows. For sensitive cell types or when off-target effects are suspected, perform a dose–response curve (1–30 μM) to identify the minimal effective concentration.
    • Toxicity and Off-Target Effects: Despite its high selectivity, prolonged exposure or excessive concentrations (>50 μM) may induce cytotoxicity or alter non-ROCK pathways. Limit exposure time to essential windows (e.g., 24–48 hours post-passage) and verify specificity via parallel controls lacking the ROCK inhibitor.
    • Storage and Stability: Store Y-27632 dihydrochloride as a solid at 4°C (desiccated) or below. Stock solutions in DMSO can be stored at -20°C for several months, but avoid long-term storage of aqueous solutions. Always check for signs of degradation or precipitation prior to use.
    • Batch-to-Batch Consistency: Source high-purity lots from reputable suppliers such as APExBIO to ensure reproducibility. Validate new batches by benchmarking cell viability and cytoskeletal assays against historical data.

    Future Outlook: Expanding the Horizons of ROCK Inhibition

    As stem cell and oncology research advance, Y-27632 dihydrochloride is poised to remain a central reagent for dissecting the Rho/ROCK signaling pathway. Its proven efficacy in supporting intermediate pluripotency states (Yu et al., 2023) and suppressing tumor invasion positions it at the intersection of regenerative medicine and cancer therapeutics. Future directions include:

    • Development of combinatorial protocols integrating Y-27632 with next-generation pathway modulators for more refined control over cell fate decisions.
    • Application in high-throughput screening platforms for drug discovery targeting cytoskeletal and metastatic processes.
    • Exploiting its role in extracellular vesicle biology to explore novel intercellular communication mechanisms, as suggested by the extracellular vesicle study.
    • Harnessing its robust performance in both 2D and 3D culture systems to advance personalized medicine, organoid biobanking, and disease modeling.

    For reliable, validated, and high-purity Y-27632 (A3008), APExBIO remains the trusted supplier for cutting-edge research applications. Explore the full product specifications and ordering information at the official Y-27632 dihydrochloride product page.

    Interlinking and Further Reading

    In summary, Y-27632 dihydrochloride is an indispensable, highly selective tool for modulating the ROCK signaling pathway, supporting robust and reproducible outcomes across stem cell, cancer, and organoid research. By following best practices for preparation, application, and troubleshooting—and sourcing from trusted suppliers like APExBIO—researchers can maximize the impact and reliability of their cell-based workflows.